Shares of Edwards Lifesciences Corp. EW slid 2.05% to $70.33 Friday, on what proved to be an all-around favorable trading ...

Shares of Edwards Lifesciences Corp. EW slipped 1.44% to $71.80 Thursday, on what proved to be an all-around dismal trading ...

Full Year 2024 Results Key Financial Results Revenue: US$5.44b (up 8.6% from FY ...

Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to ...

IRVINE, Calif., February 25, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4 ...

Becton, Dickinson and Co. (BD) has appointed longtime Edwards Lifesciences sales and marketing exec Tim Patz as the new ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion ...

Edwards Lifesciences missed analysts’ revenue expectations by 13.1% last quarter, reporting revenues of $1.35 billion, down 8.5% year on year. It was a strong quarter for the company, with an ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Embodied carbon reduction strategies helped guide the design of Edwards Lifesciences’ Mussallem Innovation Center, a mix of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...